SelectMDx improves prostate biopsy decision-making in urology practices
Go back to SelectMDx improves prostate biopsy decision-making in urology practices| (NASDAQ: MDXH) | Delayed: 0.48 -0.01 (2.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.49 | 52 Week High | $ | |||
| Open | $0.49 | 52 Week Low | $ | |||
| Day High | $0.50 | P/E | N/A | |||
| Day Low | $0.46 | EPS | $ | |||
| Volume | 473,097 | |||||

